Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Meenhorst

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
AIDS (London, England)|January 12, 2000
Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patientsB S Blank, P L Meenhorst, G J Weverling, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF)P J Bakker, S A Danner, C H ten Napel, et al.
The Journal of Infectious Diseases|August 1, 1985
Water-related nosocomial pneumonia caused by Legionella pneumophila serogroups 1 and 10P L Meenhorst, A L Reingold, D G Groothuis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2001
Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individualsA I Veldkamp, R P van Heeswijk, J W Mulder, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 20, 2002
Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patientsB S N Blank, P L Meenhorst, W Pauw, et al.
British Journal of Clinical Pharmacology|September 29, 2005
Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patientsK M L Crommentuyn, B S Kappelhoff, J W Mulder, et al.
The Journal of Infectious Diseases|September 9, 1999
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adultsD W Notermans, N G Pakker, D Hamann, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 22, 2002
Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohortL M M Wolters, H G M Niesters, B E Hansen, et al.
Therapeutic Drug Monitoring|August 15, 2000
Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavirP W Hugen, D M Burger, M de Graaff, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2000
Nevirapine plus didanosine: once or twice daily combination?R P van Heeswijk, A I Veldkamp, J W Mulder, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
AIDS (London, England)|January 12, 2000
Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patientsB S Blank, P L Meenhorst, G J Weverling, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF)P J Bakker, S A Danner, C H ten Napel, et al.
The Journal of Infectious Diseases|August 1, 1985
Water-related nosocomial pneumonia caused by Legionella pneumophila serogroups 1 and 10P L Meenhorst, A L Reingold, D G Groothuis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2001
Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individualsA I Veldkamp, R P van Heeswijk, J W Mulder, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 20, 2002
Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patientsB S N Blank, P L Meenhorst, W Pauw, et al.
British Journal of Clinical Pharmacology|September 29, 2005
Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patientsK M L Crommentuyn, B S Kappelhoff, J W Mulder, et al.
The Journal of Infectious Diseases|September 9, 1999
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adultsD W Notermans, N G Pakker, D Hamann, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 22, 2002
Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohortL M M Wolters, H G M Niesters, B E Hansen, et al.
Therapeutic Drug Monitoring|August 15, 2000
Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavirP W Hugen, D M Burger, M de Graaff, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2000
Nevirapine plus didanosine: once or twice daily combination?R P van Heeswijk, A I Veldkamp, J W Mulder, et al.
Pageof 10